BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu L, Zhang L, Zheng S. Role of the long non-coding RNA HOTAIR in hepatocellular carcinoma. Oncol Lett 2017;14:1233-9. [PMID: 28789338 DOI: 10.3892/ol.2017.6312] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Pinto DO, Scott TA, DeMarino C, Pleet ML, Vo TT, Saifuddin M, Kovalskyy D, Erickson J, Cowen M, Barclay RA, Zeng C, Weinberg MS, Kashanchi F. Effect of transcription inhibition and generation of suppressive viral non-coding RNAs. Retrovirology 2019;16:13. [PMID: 31036006 DOI: 10.1186/s12977-019-0475-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
2 Wang M, Yu F, Chen X, Li P, Wang K. The Underlying Mechanisms of Noncoding RNAs in the Chemoresistance of Hepatocellular Carcinoma. Mol Ther Nucleic Acids 2020;21:13-27. [PMID: 32505000 DOI: 10.1016/j.omtn.2020.05.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
3 Li Y, Lv M, Song Z, Lou Z, Wang R, Zhuang M. Long non-coding RNA NNT-AS1 affects progression of breast cancer through miR-142-3p/ZEB1 axis. Biomed Pharmacother 2018;103:939-46. [PMID: 29710510 DOI: 10.1016/j.biopha.2018.04.087] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 12.3] [Reference Citation Analysis]
4 Yılmaz Susluer S, Kayabasi C, Ozmen Yelken B, Asik A, Celik D, Balci Okcanoglu T, Serin Senger S, Biray Avci C, Kose S, Gunduz C. Analysis of long non-coding RNA (lncRNA) expression in hepatitis B patients. Bosn J Basic Med Sci 2018;18:150-61. [PMID: 29669510 DOI: 10.17305/bjbms.2018.2800] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
5 Zhang L, He X, Jin T, Gang L, Jin Z. Long non-coding RNA DLX6-AS1 aggravates hepatocellular carcinoma carcinogenesis by modulating miR-203a/MMP-2 pathway. Biomed Pharmacother 2017;96:884-91. [PMID: 29145165 DOI: 10.1016/j.biopha.2017.10.056] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 11.0] [Reference Citation Analysis]
6 Sun F, Wu K, Yao Z, Mu X, Zheng Z, Sun M, Wang Y, Liu Z, Zhu Y. Long Noncoding RNA PVT1 Promotes Prostate Cancer Metastasis by Increasing NOP2 Expression via Targeting Tumor Suppressor MicroRNAs. Onco Targets Ther 2020;13:6755-65. [PMID: 32764963 DOI: 10.2147/OTT.S242441] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
7 Battistelli C, Garbo S, Riccioni V, Montaldo C, Santangelo L, Vandelli A, Strippoli R, Tartaglia GG, Tripodi M, Cicchini C. Design and Functional Validation of a Mutant Variant of the LncRNA HOTAIR to Counteract Snail Function in Epithelial-to-Mesenchymal Transition. Cancer Res 2021;81:103-13. [PMID: 33158813 DOI: 10.1158/0008-5472.CAN-20-1764] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhang J, Liu L, Lin Z, Ji X, Pi L, Lin X, Tian N, Liu G, Liu Q, Lin Z, Chen S, Yu X, Gao Y. SNP‐SNP and SNP‐environment interactions of potentially functional HOTAIR SNPs modify the risk of hepatocellular carcinoma. Mol Carcinog 2019;58:633-42. [DOI: 10.1002/mc.22955] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
9 Mahpour A, Mullen AC. Our emerging understanding of the roles of long non-coding RNAs in normal liver function, disease, and malignancy. JHEP Rep 2021;3:100177. [PMID: 33294829 DOI: 10.1016/j.jhepr.2020.100177] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
10 Chen H, Yang F, Li X, Gong ZJ, Wang LW. Long noncoding RNA LNC473 inhibits the ubiquitination of survivin via association with USP9X and enhances cell proliferation and invasion in hepatocellular carcinoma cells. Biochem Biophys Res Commun 2018;499:702-10. [PMID: 29605299 DOI: 10.1016/j.bbrc.2018.03.215] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 12.3] [Reference Citation Analysis]
11 Amicone L, Marchetti A. Microenvironment and tumor cells: two targets for new molecular therapies of hepatocellular carcinoma. Transl Gastroenterol Hepatol 2018;3:24. [PMID: 29971255 DOI: 10.21037/tgh.2018.04.05] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
12 Yan J, Zhou C, Guo K, Li Q, Wang Z. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma. J Cell Biochem 2019;120:213-23. [PMID: 30206981 DOI: 10.1002/jcb.27321] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 7.7] [Reference Citation Analysis]
13 Jacob R, Zander S, Gutschner T. The Dark Side of the Epitranscriptome: Chemical Modifications in Long Non-Coding RNAs. Int J Mol Sci 2017;18:E2387. [PMID: 29125541 DOI: 10.3390/ijms18112387] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 14.0] [Reference Citation Analysis]
14 Li N, Zhu Y. Targeting liver cancer stem cells for the treatment of hepatocellular carcinoma. Therap Adv Gastroenterol 2019;12:1756284818821560. [PMID: 30719075 DOI: 10.1177/1756284818821560] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
15 Yang X, Liu M, Li M, Zhang S, Hiju H, Sun J, Mao Z, Zheng M, Feng B. Epigenetic modulations of noncoding RNA: a novel dimension of Cancer biology. Mol Cancer 2020;19:64. [PMID: 32209098 DOI: 10.1186/s12943-020-01159-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 21.0] [Reference Citation Analysis]
16 Yang T, He X, Chen A, Tan K, Du X. LncRNA HOTAIR contributes to the malignancy of hepatocellular carcinoma by enhancing epithelial-mesenchymal transition via sponging miR-23b-3p from ZEB1. Gene. 2018;670:114-122. [PMID: 29778425 DOI: 10.1016/j.gene.2018.05.061] [Cited by in Crossref: 39] [Cited by in F6Publishing: 45] [Article Influence: 13.0] [Reference Citation Analysis]
17 Anastasiadou E, Faggioni A, Trivedi P, Slack FJ. The Nefarious Nexus of Noncoding RNAs in Cancer. Int J Mol Sci 2018;19:E2072. [PMID: 30018188 DOI: 10.3390/ijms19072072] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
18 Abbastabar M, Sarfi M, Golestani A, Khalili E. lncRNA involvement in hepatocellular carcinoma metastasis and prognosis. EXCLI J 2018;17:900-13. [PMID: 30564069 DOI: 10.17179/excli2018-1541] [Cited by in F6Publishing: 49] [Reference Citation Analysis]
19 Hu S, Chang J, Li Y, Wang W, Guo M, Zou EC, Wang Y, Yang Y. Long non-coding RNA XIST as a potential prognostic biomarker in human cancers: a meta-analysis. Oncotarget 2018;9:13911-9. [PMID: 29568404 DOI: 10.18632/oncotarget.23744] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
20 Wang Y, Wan G, Wang H, Zhang G, Li Z, Lu L, Wu Y, Yu X, Du J. Mechanism of aberrant long non-coding RNA expression in an adriamycin-resistant liver cancer cell strain. Dig Liver Dis 2020;52:582-7. [PMID: 31704308 DOI: 10.1016/j.dld.2019.09.013] [Reference Citation Analysis]
21 Fan J, Zhang J, Huang S, Li P. lncRNA OSER1-AS1 acts as a ceRNA to promote tumorigenesis in hepatocellular carcinoma by regulating miR-372-3p/Rab23 axis. Biochem Biophys Res Commun 2020;521:196-203. [PMID: 31635804 DOI: 10.1016/j.bbrc.2019.10.105] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
22 Xu YZ, Chen FF, Zhang Y, Liang H, Li XJ, He C. Identification of potential long noncoding RNA associated with nasopharyngeal carcinoma using deep sequencing. J Int Med Res 2019;47:3271-81. [PMID: 31122165 DOI: 10.1177/0300060519845973] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
23 Lee JY, Ahn EH, Park HW, Kim JH, Kim YR, Lee WS, Kim NK. Association between HOX Transcript Antisense RNA Single-Nucleotide Variants and Recurrent Implantation Failure. Int J Mol Sci 2021;22:3021. [PMID: 33809601 DOI: 10.3390/ijms22063021] [Reference Citation Analysis]
24 Roshdy F, Farag MMS, El-ahwany E, Mahmode O, Mousa AA, El Talkawy M, Essawy F. Long non-coding RNA HOTAIR and HOTTIP as potential biomarkers for hepatitis C virus genotype 4-induced hepatocellular carcinoma. Egypt J Med Hum Genet 2020;21. [DOI: 10.1186/s43042-020-0048-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
25 Chao Y, Zhou D. lncRNA-D16366 Is a Potential Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma. Med Sci Monit 2019;25:6581-6. [PMID: 31475695 DOI: 10.12659/MSM.915100] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 12.5] [Reference Citation Analysis]
26 Kim IJ, Lee JY, Park HW, Park HS, Ko EJ, Sung JH, Kim NK. Association between HOTAIR lncRNA Polymorphisms and Coronary Artery Disease Susceptibility. J Pers Med 2021;11:375. [PMID: 34064346 DOI: 10.3390/jpm11050375] [Reference Citation Analysis]
27 Wang D, Chen F, Zeng T, Tang Q, Chen B, Chen L, Dong Y, Li X. Comprehensive biological function analysis of lncRNAs in hepatocellular carcinoma. Genes Dis 2021;8:157-67. [PMID: 33997162 DOI: 10.1016/j.gendis.2019.12.013] [Reference Citation Analysis]
28 Wu Y, Zhang J, Zhang X, Zhou H, Liu G, Li Q. Cancer Stem Cells: A Potential Breakthrough in HCC-Targeted Therapy. Front Pharmacol 2020;11:198. [PMID: 32210805 DOI: 10.3389/fphar.2020.00198] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
29 Dinescu S, Ignat S, Lazar AD, Constantin C, Neagu M, Costache M. Epitranscriptomic Signatures in lncRNAs and Their Possible Roles in Cancer. Genes (Basel) 2019;10:E52. [PMID: 30654440 DOI: 10.3390/genes10010052] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 17.5] [Reference Citation Analysis]